References
- BORN, S. L., CAUDILL, D., SMITH, B. J. and LEHMAN-MCKEEMAN, L. D., 2000, In vitro kinetics of coumarin 3,4-epoxidation: application to species differences in toxicity and carcinogenicity, Toxocologkal Sciences, 58, 23–31.
- BORN, S. L., RODRIGUEZ, P. A., EDDY, C. L. and LEHMAN-MCKEEMAN, L. D., 1997, Synthesis and reactivity of coumarin 3,4-epoxide. Drug Metabolism and Disposition, 35, 1318–1323.
- COK, I., KOCABAS, N. A., CHOLERTON, S., KARAKAYA, A. E. and SARDA S., 2001, Determination of coumarin metabolism in Turkish population. Human and Experimental Toxicology, 20, 179–184. CREIGHTON, T. E., 1993, Proteins: Structure and Molecular Properties (New York: Freeman).
- DING, X., PENG, H.-M. and COON, M. J., 1994, Heterologous expression and structure—function analysis of CYP2A10 and CYP2A11 which differ in only eight amino acids but have strikingly different activities toward testosterone and coumarin. In M. C. Lechner (ed.), Cytochronze P450 8th International Conference (Paris: Libbey), pp. 885–888.
- GOTOH, O., 1992, Substrate recognition sites in cytochrome P450 family 2 (CYP2) inferred from comparative analyses of amino acid and coding nucelotide sequences. Journal of Biological Chemistry, 267, 83–90.
- HANIOKA, N., GONZALEZ, F. J., LINDBERG, N. A., Liu, G., GELBOIN, H. V. and KORZEKWA, K. R., 1992, Site-directged mutagenesis of cytochromes P405 CYP2A1 and CYP2A2: influence of the distal helix on the kinetics of testosterone hydroxylation. Biochemistry, 31, 3364–3370.
- JUVONEN, R. O., IwAsAxi, M. and NEGISHI, M., 1991, Structural function of residue 209 in coumarin 7-hydroxylase (P450c0h)• Journal of Biological Chemistry, 266, 16431–16435.
- LAKE, B. G., 1999, Coumarin metabolism, toxicity and carcinogenicity: relevance for human risk assessment. Food and Chemical Toxicology, 37, 423–453.
- LEWIS, D. F. V., 1998, The CYP2 family: models, mutants and interactions. Xenobiotica, 28, 617-661. LEWIS, D. F. V., 2002, Homology modelling of CYP2 family enzymes based on the CYP2C5 crystal structure. Xenobiotica, 32, 305–323.
- LEWIS, D. F. V. and DICKINS, M., 2002, Factors influencing rates and clearance in P450-mediated reactions. Toxicology, 170, 45–53.
- LEWIS, D. F. V. and LAKE, B. G., 1995, Molecular modelling of members of the P4502A subfamily: application to studies of enzyme specificity. Xenobiotica, 25, 585–598.
- LEWIS, D. F. V., DICKINS, M., LAKE, B. G., EDDERSHAW, P. J., TARBIT, M. H. and GOLDFARB, P. S., 1999, Molecular modelling of the human cytochrome P450 isoforrn CYP2A6 and investigations of CYP2A substrate selectivity. Toxicology, 133, 1–33.
- LEWIS, D. F. V., MODI, S. and DICKINS, M., 2002, Quantitative structure-activity relationships for substrates and inhibitors of human cytochromes P450. Drug Metabolism Reviews, 34 (in press).
- Li, H. and PouuLos, T. L., 1997, The structure of the cytochrome P450Bm_3 haem domain complexed with the fatty acid substrate, palmitoleic acid. Nature Structural Biology, 4, 140–146.
- LINDBERG, R. L. P. and NEGISHI, M., 1989, Alteration of mouse cytochrome P450coh substrate specificity by mutation of a single acid residue. Nature, 339, 617–661.
- NEGISHI, M., IWASAKI, M., JUVONEN, R. O., SUEYOSHI, T., DARDEN, T. A. and PEDERSEN, L. G., 1996, Structural flexibility and functional versatility of cytochrome P450 and rapid evolution. Mutation Research, 350, 43–50.
- PELKONEN, O., RAUTIO, A., RAUNIO, H. and PASANEN, M., 2000, CYP2A6: a human coumarin 7-hydroxylase. Toxicology, 144, 139–147.
- POUWS, T. L., FINZEL, B. C. and HOWARD, A. J., 1986, Crystal structure of substrate-free Pseudomonas putida cytochrome P450. Biochemistry, 25, 5314–5322.
- POUWS, T. L., FINZEL, B. C. and HOWARD, A. J., 1987, High-resolution crystal structure of cytochrome P450c.m. Journal of Molecular Biology, 195, 687–700.
- RAVICHANDRAN, K. G., BODDUPALLI, S. S., HASEMANN, C. A., PETERSON, J. A. and DEISENHOFER, J., 1993, Crystal structure of hemoprotein domain of P450Bm_3, a prototype for microsomal P450s. Science, 261, 731–736.
- RENDIC, S. and DiCmu,o, F. J., 1997, Human cytochrome P450 enzymes: a status report summarizing their reactions, substrates, inducers and inhibitors. Drug Metabolism Reviews, 29, 413–580.
- SUZUXI, T. and KUDO, Y., 1990, Automatic log P estimation based on combined additive modeling methods. Journal of Computer-Aided Molecular Design, 4, 155–198.
- WILLIAMS, P. A., COSME, J., SRIDHAR, V., JOHNSON, E. F. and McREE, D. E., 2000, Mammalian microsomal cytochrome P450 monooxygenase: structural adaptations for membrane binding and functional diversity. Molecular Cell, 5, 121–131.